TORwards a Victory Over Aging

January 1, 2020

Lamming DW, Salmon AB J Gerontol A Biol Sci Med Sci. 2020 Jan 1;75(1):1-3. doi: 10.1093/gerona/glz212.


Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets.

October 12, 2018

Sills AM, Artavia JM, DeRosa BD, Ross CN, Salmon AB American Journal of Primatology. 2018 Oct 12:e22927. doi: 10.1002/ajp.22927. [Epub ahead of print]. Abstract: Interventions to extend lifespan and improve health with increasing age would have significant impact on a growing aged population. There are now several pharmaceutical interventions that extend lifespan in laboratory rodent [...]

Hydrogen sulfide ameliorates aging-associated changes in the kidney.

May 1, 2018

Lee HJ, Feliers D, Barnes JL, Oh S, Choudhury GG2, Diaz V, Galvan V, Strong R, Nelson J, Salmon A, Kevil CG, Kasinath BS Geroscience. 2018 Apr;40(2):163-176. doi: 10.1007/s11357-018-0018-y. Epub 2018 May 1. PMCID: PMC5964063 Abstract Aging is associated with replacement of normal kidney parenchyma by fibrosis. Because hydrogen sulfide (H2S) ameliorates kidney fibrosis in […]


Moving toward ‘common’ use of the marmoset as a non-human primate aging model

July 22, 2016

Moving toward ‘common’ use of the marmoset as a non-human primate aging model Adam B. Salmon Pathobiol Aging Age Relat Dis. 2016; 6: 10.3402/pba.v6.32758. Published online 2016 Jul 22. doi: 10.3402/pba.v6.32758 Abstract Great leaps forward in our understanding of the basic biology of aging, including interventions that extend longevity, have come about from using common [...]